% | $
Quotes you view appear here for quick access.

Aegerion Pharmaceuticals, Inc. (AEGR) Message Board

  • tnorman61 tnorman61 Apr 11, 2014 8:31 AM Flag

    Innocent investors may mistake this propaganda

    "innocent investors" have no business in a stock like AEGR.
    A one-product company under serious attack,
    with no bottom in sight.
    Who do I blame for this?
    Obviously, I blame management.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • There may be some "innocent investors" in 401k programs, but independent investors sometimes can be blind investors. A small cap company such as $AEGR is indeed no place for blind investors. However, for those doing their homework, and watching this stock daily, AEGR may be a great long-term investment. The company expects revenue of $212M this year. Assuming a 75% profit margin (reasonable for this high priced orphan drug and because I take expenses into account - even for startups), and the typical NASDAQ P/E multiple of 20x, that would put AEGR over a $3B market cap. It, currently, is around $1B. Thus, there is a potential for at least a 3x stock price increase (although small cap biotechs have been known to trade at even higher levels). Eye opening information, eh?

      Sentiment: Buy

13.56+0.37(+2.81%)Oct 2 4:00 PMEDT